Previous research showed that silencing of YAP expression enhanced the in vitro sensitivity to MEK and RAF inhibitors in lung cancer, colon cancer, melanoma, pancreatic cancer and thyroid cancer.26 This evidence concerns the gene MAP2K7 and thyroid gland carcinoma.